当前位置:首页 - 行情中心 - 亨迪药业(301211) - 财务分析 - 现金流量表

亨迪药业

(301211)

  

流通市值:44.01亿  总市值:44.02亿
流通股本:4.18亿   总股本:4.18亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金282,940,655.12199,912,769.7188,459,233.81374,834,722.08
  收到的税费返还6,181,619.452,346,312.792,196,989.18,338,284.74
  收到其他与经营活动有关的现金10,666,999.69,321,901.6520,944,057.5523,615,243.59
  经营活动现金流入小计299,789,274.17211,580,984.15111,600,280.46406,788,250.41
  购买商品、接受劳务支付的现金128,559,964.0183,443,395.7744,442,656.76206,998,897.33
  支付给职工以及为职工支付的现金82,582,530.0556,999,267.5331,215,673.86108,119,795.68
  支付的各项税费12,313,858.568,310,334.213,374,444.3917,011,897.47
  支付其他与经营活动有关的现金56,162,160.3230,139,949.4335,030,319.4567,106,840.47
  经营活动现金流出小计279,618,512.94178,892,946.94114,063,094.46399,237,430.95
  经营活动产生的现金流量净额20,170,761.2332,688,037.21-2,462,8147,550,819.46
二、投资活动产生的现金流量:
  收回投资收到的现金---474,955,491.68
  取得投资收益收到的现金---15,762,324.96
  处置固定资产、无形资产和其他长期资产收回的现金净额135,64969,000-31,515
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计135,64969,000-490,749,331.64
  购建固定资产、无形资产和其他长期资产支付的现金54,329,523.5734,526,651.4319,186,893.0652,329,363.84
  投资支付的现金---475,707,930.08
  投资活动现金流出小计54,329,523.5734,526,651.4319,186,893.06528,037,293.92
  投资活动产生的现金流量净额-54,193,874.57-34,457,651.43-19,186,893.06-37,287,962.28
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金25,056,00025,056,000-72,000,000
  支付其他与筹资活动有关的现金-1,268,079.16-1,402,643.11
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计25,056,00026,324,079.16-73,402,643.11
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-25,056,000-26,324,079.16--73,402,643.11
四、汇率变动对现金及现金等价物的影响-3,071,283.97-1,987,849.21-725,827.95-1,141,506.19
五、现金及现金等价物净增加额-62,150,397.31-30,081,542.59-22,375,535.01-104,281,292.12
  加:期初现金及现金等价物余额438,758,499.51438,758,499.51447,658,499.51543,039,791.63
  期末现金及现金等价物余额376,608,102.2408,676,956.92425,282,964.5438,758,499.51
补充资料:
  净利润-30,136,061.88-34,910,598.79
  资产减值准备---4,346,634.5
  固定资产和投资性房地产折旧-22,758,434.1-40,080,521.37
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-22,758,434.1-40,080,521.37
  无形资产摊销-1,218,602.24-2,113,037.64
  长期待摊费用摊销-150,673.53-285,693.36
  处置固定资产、无形资产和其他长期资产的损失--4,590.71--11,870.67
  固定资产报废损失---17,007.64
  公允价值变动损失--14,892,277.77--12,969,750.06
  财务费用-3,334,412.11-1,320,552.89
  投资损失----16,165,741.61
  递延所得税---781,086.19
  其中:递延所得税资产减少----370,529.73
    递延所得税负债增加---1,151,615.92
  存货的减少--16,662,167.37-10,827,036.32
  经营性应收项目的减少-8,220,485.42--14,141,118.35
  经营性应付项目的增加--1,738,413.76--45,256,325.83
  现金的期末余额-408,676,956.92-438,758,499.51
  减:现金的期初余额-438,758,499.51-543,039,791.63
  现金及现金等价物的净增加额--30,081,542.59--104,281,292.12
公告日期2026-10-272026-08-252026-04-232026-03-31
审计意见(境内)标准无保留意见
TOP↑